FOXO Technologies Inc. (NYSEAMERICAN:FOXO) Sees Large Drop in Short Interest

FOXO Technologies Inc. (NYSEAMERICAN:FOXO) was the target of a significant drop in short interest in February. As of February 15th, there was short interest totalling 895,600 shares, a drop of 28.9% from the January 31st total of 1,260,000 shares. Currently, 4.3% of the company’s stock are short sold. Based on an average daily volume of 9,270,000 shares, the short-interest ratio is presently 0.1 days.

Institutional Trading of FOXO Technologies

An institutional investor recently bought a new position in FOXO Technologies stock. Jane Street Group LLC bought a new stake in FOXO Technologies Inc. (NYSEAMERICAN:FOXO) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm bought 117,047 shares of the company’s stock, valued at approximately $34,000. Jane Street Group LLC owned 0.67% of FOXO Technologies as of its most recent SEC filing. Institutional investors own 44.89% of the company’s stock.

FOXO Technologies Price Performance

FOXO stock traded down $0.01 during trading hours on Tuesday, reaching $0.16. The stock had a trading volume of 1,296,945 shares, compared to its average volume of 9,697,931. The company’s 50-day moving average is $0.28. FOXO Technologies has a fifty-two week low of $0.13 and a fifty-two week high of $1.30.

FOXO Technologies Company Profile

FOXO Technologies Inc engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging.